What the FDA labels say about taking them together
Rosuvastatin and tedizolid
Tedizolid's FDA label of February 27, 2026 names rosuvastatin in its drug interactions section; the rosuvastatin labels PlainMeds reads (2) do not name tedizolid. The tedizolid label: “If coadministration cannot be avoided, monitor for adverse reactions related to the concomitantly administered BCRP substrates, including rosuvastatin.”
Check it at the source: the rosuvastatin FDA label on DailyMed (effective September 4, 2026, ScieGen Pharmaceuticals, Inc.); the tedizolid FDA label on DailyMed (effective February 27, 2026, Merck Sharp & Dohme LLC).
What does the rosuvastatin label say about tedizolid?
Rosuvastatin's label (effective September 4, 2026) and its 1 other brand-application label do not name tedizolid in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Rosuvastatin), ScieGen Pharmaceuticals, Inc., effective September 4, 2026 (SPL set ee4933c5-0d97-494d-ac0f-2083e0100836), via openFDA; the full label on DailyMed
What does the tedizolid label say about rosuvastatin?
Tedizolid label, drug interactionsIf coadministration cannot be avoided, monitor for adverse reactions related to the concomitantly administered BCRP substrates, including rosuvastatin [see Clinical Pharmacology (12.3) ].
Source: FDA drug label (SIVEXTRO), NDA205436 (Cubist Pharms Llc), as published by Merck Sharp & Dohme LLC, effective February 27, 2026 (SPL set 75672079-589f-451a-bdbf-eaebcfcc80a9), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Rosuvastatin | Tedizolid | |
|---|---|---|
| Labeled for | Heart attack and coronary artery disease, High cholesterol, High triglycerides, Stroke prevention | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $0.0692 per tablet 40 mg tablet | $475.79 per tablet 200 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once